Novartis Pushes Pipeline But Keeps An Eye On Alcon

Source: Seeking Alpha

Wednesday, April 26, 2017 | Earnings & Financials , Alcon

Investors reacted well to a decent first quarter from Novartis that suggested that the long-awaited turnaround in its Alcon eyecare division has begun. While there is still investment needed, especially in the surgical side of the unit, there are hopes that the worst is now behind it - though this will need to be borne out over the rest of the year.

Open in New Window


You must be logged in to leave a comment.